Research and Publication Ethics

 

Table of contents

A. General Principles

B. Authorship and Contributorship

C. Originality, Duplicate Publication, Secondary Publication, and Preprints

D. Conflicts of Interest, Funding, Copyright, and Open Access

E. Human Research, Animal Research, Informed Consent, and Case Reports

F. Reporting Guidelines and Clinical Trial Registration

G. Use of Artificial Intelligence and Automated Tools

H. Data Availability, Archiving, and Repository Deposit

I. Peer Review, Editorial Independence, and Confidentiality

J. Publication Misconduct, Corrections, and Retractions

 

 

The Journal of Implantology and Applied Sciences follows the ICMJE Recommendations and the Principles of Transparency and Best Practice in Scholarly Publishing. This document is the journal’s authoritative policy for research and publication ethics.

 

 

A. General Principles

The journal is committed to integrity, transparency, protection of research participants, and editorial independence. Authors, reviewers, editors, and the publisher must comply with these principles and applicable laws and institutional requirements..

 

B. Authorship and Contributorship

∙ Authors must meet all four ICMJE authorship criteria. All authors must approve the submitted version and the final version to be published and accept accountability for the work. The journal does not allow multiple corresponding authors for one article.
∙ Manuscripts of all types (Original Articles, Review Articles, Case Reports, and Dental Technique articles) should have no more than five authors. When additional authors are essential because of the study’s design or conduct, the corresponding author must submit a signed explanatory letter describing each additional author’s substantial contribution and obtain approval from the Editor-in-Chief. Changes to authorship after submission require written agreement from all authors and approval by the Editor-in-Chief.
∙ Authors must provide a contribution statement. Persons who do not meet authorship criteria should be acknowledged with their permission.

 

C. Originality, Duplicate Publication, Secondary Publication, and Preprints

∙ Submitted manuscripts must not have been published previously or be under consideration elsewhere, except for secondary publication permitted under the ICMJE Recommendations. Disclosed preprints are permitted. The journal may use similarity-checking tools; all findings are assessed by an editor before a decision is made.
∙ Secondary publication is considered only when it meets the current ICMJE Recommendations. Posting on a recognized preprint server before submission is permitted if disclosed in the cover letter and manuscript, including the server name and persistent identifier. A preprint is not duplicate publication; after publication, authors should link it to the Version of Record.
∙ Authors must acknowledge the original source of reproduced or adapted material and obtain permission from the copyright holder where required by the applicable license.

 

D. Conflicts of Interest, Funding, Copyright, and Open Access

∙ Each author must disclose financial and nonfinancial conflicts of interest. All funding sources and the role of the funder in study design, data collection, analysis, manuscript preparation, and publication decisions must be stated. If there was no funding, authors must state “No funding.”
∙ Copyright in accepted articles is transferred to the Korean Academy of Oral & Maxillofacial Implantology (KAOMI) in accordance with the journal’s copyright transfer agreement. Articles are distributed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0; https://creativecommons.org/licenses/by-nc/4.0/).

 

E. Human Research, Animal Research, Informed Consent, and Case Reports

∙ Human research must comply with the Declaration of Helsinki and applicable laws. Authors must state the name of the reviewing body, approval number, and approval date; if approval is waived or unnecessary, the reason must be stated. Informed consent must be obtained from human research participants unless waived by the reviewing ethics committee. Consent or its waiver must be stated in the manuscript.
∙ Reports of animal research must identify the approving committee, approval number, and institutional standards followed. Written consent for publication is required for case reports, case series, and potentially identifiable images or clinical information. Identifying information must be anonymized.

 

F. Reporting Guidelines and Clinical Trial Registration

Authors must follow the reporting guideline appropriate to the study design, such as CONSORT, PRISMA, STROBE, CARE, ARRIVE, or STARD, and submit the relevant checklist where available. Clinical trials must be registered in a WHO- or ICMJE-recognized registry at or before enrollment of the first participant, and the registry name and registration number must be reported in the manuscript.

 

G. Use of Artificial Intelligence and Automated Tools

∙ Generative artificial intelligence (AI) and other automated tools do not qualify for authorship. At submission, authors must disclose substantive use of such tools in the manuscript or cover letter. Authors remain fully responsible for the accuracy, originality, citations, confidentiality, and integrity of all submitted content.
∙ Reviewers and editors must not upload manuscripts, data, figures, or peer-review materials to publicly accessible generative AI tools. Any automated screening used by the journal is subject to human review and final editorial judgment.

 

H. Data Availability, Archiving, and Repository Deposit

∙ Original Articles, Review Articles, and reports of clinical trials must include a data availability statement specifying whether data are publicly available, available on reasonable request, or unavailable, with the repository name and a persistent identifier where applicable. Restrictions necessary to protect privacy, consent, confidentiality, or legal rights must be explained.
∙ The journal’s long-term digital preservation arrangements have not yet been finalized.
∙ Authors may deposit the preprint, accepted manuscript, and published Version of Record in institutional or subject repositories without embargo. Once the Version of Record is published, repository records must include an accurate citation and a link to it.

 

I. Peer Review, Editorial Independence, and Confidentiality

∙ The journal uses double-blind peer review and normally obtains at least two expert reviews. Editors and reviewers must disclose conflicts of interest, recuse themselves from handling manuscripts when such conflicts exist, and keep manuscripts and peer-review materials confidential.
∙ A manuscript authored by an editor, editorial board member, or reviewer must be handled by an independent editor who has no conflict of interest. The author concerned must not participate in reviewer selection, editorial assessment, or publication decisions and must not access confidential editorial records relating to that manuscript. Editorial decisions are independent of the journal owner, advertisers, sponsors, and commercial interests.

 

J. Publication Misconduct, Corrections, and Retractions

∙ Allegations of duplicate publication, plagiarism, fabrication, falsification, undisclosed conflicts of interest, inappropriate authorship, reviewer misconduct, or other ethical concerns will be assessed in accordance with guidance from the Committee on Publication Ethics (COPE). Parties will be given an appropriate opportunity to respond.
∙ When needed to maintain the scholarly record, the journal will publish corrections, expressions of concern, retractions, or apologies, while preserving the article record and clearly identifying the publication status.

 

Version: September 2026